The complexity and immense omics data transform work into the big data age of biology and biomedicine. The recent advancement in sequencing technology has contributed to exponentiality in the amount of high-capacity data being generated. Life scientists fall into the flooding of big data from the omics experiment. The data integration is an effective method to solve the complex problem. These omics data hold the key to new research discoveries and are promising to revolutionize healthcare. Yet processing the data is the biggest challenge. Present methods are often too hard to use, and the research takes too long.
MarketsandMarkets Digital Event on Big-Omics data analysis for effective diagnostics will serve as networking place for professors, researchers and students from all diagnostic fields and provide a worldwide discussion platform for the dissemination of authentic research findings, new concepts and practical learning studies to meet the challenges in the field. Our goal is to combine Diagnostics network researchers, lecturers and scientists and to create a road for energetic exchange of understanding on technical traits, new scientific innovations, and the efficiency of diverse regulatory board.
CEO, COO, Senior scientist, Research scientist, NGS specialist, NGS scientist, Proteomics specialist, Bioinformatician scientist, Personalized medicine individuals from Pharma/Therapeutics companies
Clinical Genomics scientist, Genomics lead scientist, Microbiologist, biologists, pathologist, General Practitioners, Lab managers, Lab directors, Medical directors, Bioinformatician from NHS and Private Hospitals
Professors, Researchers, Associate professors in Genomics and Proteomics from academia